Mixlab, Inc. – Trademark Portfolio
Entity Type: 03
Mixlab, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include MIXLAB. The owner is based in New York, NY.
336 West 37th St., Suite 850
New York, NY 10018
Showing of trademarks Trademarks
Trademark Classifications
Mixlab, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Mixlab, Inc. have?
Mixlab, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.
What trademark classes does Mixlab, Inc. file in?
Mixlab, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Mixlab, Inc.'s most well-known trademarks?
Mixlab, Inc.'s registered trademark portfolio includes well-known marks such as MIXLAB. These are among 1 currently registered trademark in the portfolio.
What is Mixlab, Inc.'s trademark registration success rate?
Mixlab, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.